These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 32358407)
1. Impact of neoadjuvant chemotherapy on survival prognosis and pathological downstaging in patients presenting with high-risk upper tract urothelial carcinoma: A protocol for systematic review and meta analysis. Li K; Xie W; Gao L; Huang G; Zhou J; Mei B; Chen J Medicine (Baltimore); 2020 May; 99(18):e20184. PubMed ID: 32358407 [TBL] [Abstract][Full Text] [Related]
2. Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: A systematic review and meta-analysis. Kim DK; Lee JY; Kim JW; Hah YS; Cho KS Crit Rev Oncol Hematol; 2019 Mar; 135():59-65. PubMed ID: 30819447 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis. Quhal F; Mori K; Sari Motlagh R; Laukhtina E; Pradere B; Rouprêt M; Necchi A; Moschini M; Shariat SF Int J Clin Oncol; 2020 Jun; 25(6):1037-1054. PubMed ID: 32206939 [TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy. Leow JJ; Chong YL; Chang SL; Valderrama BP; Powles T; Bellmunt J Eur Urol; 2021 May; 79(5):635-654. PubMed ID: 32798146 [TBL] [Abstract][Full Text] [Related]
5. Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy. Fletcher SA; Pallauf M; Watts EK; Lombardo KA; Campbell JA; Rezaee ME; Rouprêt M; Boorjian SA; Potretzke AM; Roshandel MR; Ploussard G; Djaladat H; Ghoreifi A; Mari A; Campi R; Khene ZE; Raman JD; Kikuchi E; Rink M; Abdollah F; Boormans JL; Fujita K; D'Andrea D; Soria F; Breda A; Hoffman-Censits J; McConkey DJ; Shariat SF; Pradere B; Singla N Eur Urol Oncol; 2024 Oct; 7(5):1061-1068. PubMed ID: 38262800 [TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant Chemotherapy Benefits Survival in High-Grade Upper Tract Urothelial Carcinoma: A Propensity Score-Based Analysis. Chen L; Ou Z; Wang R; Zhang M; He W; Zhang J; Zu X; Yi L; Xu R; Jiang S; Qi L; Wang L Ann Surg Oncol; 2020 Apr; 27(4):1297-1303. PubMed ID: 31853757 [TBL] [Abstract][Full Text] [Related]
7. Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study. Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Morita S; Kosaka T; Mizuno R; Arita Y; Akita H; Jinzaki M; Kikuchi E; Oya M Urol Oncol; 2022 Mar; 40(3):105.e19-105.e26. PubMed ID: 34454822 [TBL] [Abstract][Full Text] [Related]
10. Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study. Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YD; Ha YS; Kim TH; Kwon TG; Byun SS; Jeh SU; Kim WJ J Korean Med Sci; 2017 Feb; 32(2):335-342. PubMed ID: 28049247 [TBL] [Abstract][Full Text] [Related]
11. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review. Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401 [TBL] [Abstract][Full Text] [Related]
15. Impact of histologic variants on the oncological outcomes of patients with upper urinary tract cancers treated with radical surgery: a multi-institutional retrospective study. Murakami Y; Matsumoto K; Ikeda M; Hirayama T; Utsunomiya T; Koguchi D; Matsuda D; Okuno N; Taoka Y; Irie A; Iwamura M Int J Clin Oncol; 2019 Nov; 24(11):1412-1418. PubMed ID: 31197556 [TBL] [Abstract][Full Text] [Related]
16. Effects of Adjuvant Chemotherapy on Locally Advanced Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis. Kim DK; Kim JW; Jung HD; Ahn HK; Lee JY; Cho KS Clin Genitourin Cancer; 2019 Dec; 17(6):e1193-e1202. PubMed ID: 31543442 [TBL] [Abstract][Full Text] [Related]
17. Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate data. Ricci AD; Rizzo A; Mollica V; Schiavina R; Fiorentino M; Brunocilla E; Ardizzoni A; Massari F Anticancer Drugs; 2022 Jan; 33(1):e61-e68. PubMed ID: 34387596 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Real-World, Retrospective Study. Lee J; Lim SH; Chung JH; Song W; Sung HH; Jeong BC; Park SH Cancer Res Treat; 2024 Jul; 56(3):871-876. PubMed ID: 38228080 [TBL] [Abstract][Full Text] [Related]
19. Differential Effect of Sex on Outcomes after Radical Surgery for Upper Tract and Bladder Urothelial Carcinoma: A Systematic Review and Meta-Analysis. Mori K; Mostafaei H; Enikeev DV; Lysenko I; Quhal F; Kimura S; Karakiewicz PI; Egawa S; Shariat SF J Urol; 2020 Jul; 204(1):58-62. PubMed ID: 31995432 [TBL] [Abstract][Full Text] [Related]